Literature DB >> 28974633

Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort.

Linda S Johnson1, Nick Mattsson2, Ahmad Sajadieh2, Per Wollmer2, Martin Söderholm2.   

Abstract

BACKGROUND AND
PURPOSE: Low serum potassium is associated with stroke in populations with cardiovascular disease, hypertension, and diabetes mellitus but has not been studied in a mainly healthy population. We aimed to study the relation between serum potassium and incident stroke and mortality in the Malmö Preventive Project, a large cohort with screening in early mid-life and follow-up >25 years.
METHODS: Serum potassium measurements and covariates were available in 21 353 individuals (79% men, mean age 44 years). Mean follow-up time was 26.9 years for stroke analyses and 29.3 years for mortality analyses. There were 2061 incident stroke events and 8709 deaths. Cox regression analyses adjusted for multiple stroke risk factors (age, sex, height, weight, systolic blood pressure, fasting blood glucose, serum sodium, current smoking, prevalent diabetes mellitus, prevalent coronary artery disease, and treatment for hypertension) were fitted.
RESULTS: There was an independent, linear association between serum potassium, per mmol/L increase, and both stroke (hazard ratio, 1.33; 95% confidence interval, 1.17-1.52; P<0.0001) and mortality (hazard ratio, 1.20; 95% confidence interval, 1.13-1.28; P<0.0001). This was significant in subjects both older and younger than the median age (46.5 years), and there was evidence of an interaction with serum sodium. The association was positive and significant for both ischemic stroke and intracerebral hemorrhage and in both hypertensive and normotensive subjects.
CONCLUSIONS: Serum potassium, measured in early mid-life, was linearly associated with both incidence of ischemic stroke and intracerebral hemorrhage and all-cause mortality. An interaction with serum sodium implies that factors related to electrolyte balance and incident hypertension may be mediating factors.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  epidemiology; mortality; population; potassium; risk factor; sodium; stroke

Mesh:

Substances:

Year:  2017        PMID: 28974633     DOI: 10.1161/STROKEAHA.117.018148

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.

Authors:  Ali Reza Sobhani; Hossein Farshidi; Fariba Azarkish; Mahdiya Eslami; Ebrahim Eftekhar; Mansoor Keshavarz; Nepton Soltani
Journal:  Clin Pharmacol       Date:  2020-09-25

2.  Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.

Authors:  Yujuan Yuan; Nanfang Li; Yan Liu; Menghui Wang; Mulalibieke Heizhati; Qing Zhu; Xiaoguang Yao; Qin Luo
Journal:  Endocrine       Date:  2021-11-15       Impact factor: 3.633

3.  The association between serum glucose to potassium ratio on admission and short-term mortality in ischemic stroke patients.

Authors:  Yuzhao Lu; Xin Ma; Xiaobing Zhou; Yang Wang
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

4.  Multimodal imaging of hemorrhagic transformation biomarkers in an ischemic stroke model.

Authors:  M J Pushie; M Messmer; N J Sylvain; J Heppner; J M Newton; H Hou; M J Hackett; M E Kelly; L Peeling
Journal:  Metallomics       Date:  2022-04-30       Impact factor: 4.636

5.  Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.

Authors:  Ankur A Dashputre; Keiichi Sumida; Praveen K Potukuchi; Suryatapa Kar; Yoshitsugu Obi; Fridtjof Thomas; Miklos Z Molnar; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephron       Date:  2021-03-22       Impact factor: 2.847

6.  Fasting serum potassium and long-term mortality in healthy men.

Authors:  Ragnhild S Falk; Trude Eid Robsahm; Jan Erik Paulsen; Tanja Stocks; Isabel Drake; Trond Heir
Journal:  BMC Public Health       Date:  2021-04-13       Impact factor: 3.295

7.  Enriching the Study Population for Ischemic Stroke Therapeutic Trials Using a Machine Learning Algorithm.

Authors:  Jenish Maharjan; Yasha Ektefaie; Logan Ryan; Samson Mataraso; Gina Barnes; Sepideh Shokouhi; Abigail Green-Saxena; Jacob Calvert; Qingqing Mao; Ritankar Das
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.086

8.  Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.

Authors:  Ankur A Dashputre; Keiichi Sumida; Fridtjof Thomas; Justin Gatwood; Oguz Akbilgic; Praveen K Potukuchi; Yoshitsugu Obi; Miklos Z Molnar; Elani Streja; Kamyar Kalantar Zadeh; Csaba P Kovesdy
Journal:  Am J Nephrol       Date:  2021-07-21       Impact factor: 4.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.